Page last updated: 2024-08-26

nicotine and u-50488

nicotine has been researched along with u-50488 in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (25.00)18.2507
2000's5 (31.25)29.6817
2010's6 (37.50)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Babovic-Vuksanovic, D; Heidbreder, CA; Shippenberg, TS; Shoaib, M1
Hamann, SR; Martin, WR; Parvini, S1
Choi, SR; Kim, YH; Lee, KJ; Song, DK; Suh, HW1
Choi, SR; Chung, KM; Kim, YH; Song, DK; Suh, HW1
Hahn, B; Shoaib, M; Stolerman, IP1
Ise, Y; Nagase, H; Narita, M; Suzuki, T1
Baba, S; Hiramatsu, M; Kojima, R; Nabeshima, T; Watanabe, M1
Guaza, C; Llorente, R; Marco, EM; Moreno, E; Pérez-Alvarez, L; Viveros, MP1
Cavun, S; Göktalay, G; Hamilton, JR; Levendusky, MC; Millington, WR1
Ismayilova, N; Shoaib, M1
Bruchas, MR; Chavkin, C; Gustin, RM; Martinelli, E; Schindler, AG; Smith, JS1
Natividad, LA; O'Dell, LE; Orfila, JE; Tejeda, HA; Torres, OV1
Coen, K; Funk, D; Grella, SL; Lê, AD; Li, Z1
D'Souza, MS; Norman, H; Ward, M1
Coen, K; Fletcher, PJ; Funk, D; Lê, AD; Tamadon, S1
D'Souza, MS; Pham, H; Seeley, SL1

Other Studies

16 other study(ies) available for nicotine and u-50488

ArticleYear
Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Behavior, Animal; Benzeneacetamides; Cocaine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Locomotion; Male; Nicotine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sensitivity and Specificity; Sodium Chloride

1995
Pharmacologic characteristics of a medullary hyperalgesic center.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Ethylketocyclazocine; Female; Hyperalgesia; Medulla Oblongata; Morphine; Nicotine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reflex

1993
Intrathecally injected nicotine enhances the antinociception induced by morphine but not beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intrathecally in the mouse.
    Neuropeptides, 1996, Volume: 30, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Analgesics, Opioid; Analysis of Variance; Animals; beta-Endorphin; Drug Synergism; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Nicotine; Pyrrolidines; Receptors, Opioid, delta; Spinal Cord

1996
Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse.
    Neuropeptides, 1996, Volume: 30, Issue:5

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; beta-Endorphin; Drug Synergism; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Morphine; Nicotine; Nociceptors; Pain; Pain Measurement; Pyrrolidines; Receptors, Opioid, delta; Receptors, Opioid, kappa

1996
Kappa-opioid receptor modulation of nicotine-induced behaviour.
    Neuropharmacology, 2000, Volume: 39, Issue:13

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Behavior, Animal; Benzeneacetamides; Benzofurans; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Motor Activity; Naltrexone; Nicotine; Nicotinic Agonists; Pyrrolidines; Rats; Receptors, Opioid, kappa

2000
Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Neuroscience letters, 2002, Apr-26, Volume: 323, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Aversive Therapy; Conditioning, Psychological; Male; Mecamylamine; Morphinans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Spiro Compounds; Substance Withdrawal Syndrome

2002
Alpha 7-type nicotinic acetylcholine receptor and prodynorphin mRNA expression after administration of (-)-nicotine and U-50,488H in beta-amyloid peptide (25-35)-treated mice.
    Annals of the New York Academy of Sciences, 2004, Volume: 1025

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Enkephalins; Gene Expression Regulation; Male; Mice; Nicotine; Peptide Fragments; Protein Precursors; Receptors, Nicotinic; RNA, Messenger

2004
The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety.
    Behavioural brain research, 2005, Sep-08, Volume: 163, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Corticosterone; Drug Interactions; Endocrine System; Male; Maze Learning; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Opioid, kappa

2005
Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Avoidance Learning; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Time Factors

2006
Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats.
    Psychopharmacology, 2010, Volume: 210, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Dose-Response Relationship, Drug; Feeding Behavior; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nicotine; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Self Administration; Tobacco Use Disorder

2010
Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Jan-25, Volume: 32, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amygdala; Animals; Conditioning, Operant; Dynorphins; Male; Mice; Mice, Inbred C57BL; Nicotine; Receptors, Opioid, kappa; Stress, Psychological; Swimming

2012
Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.
    Psychopharmacology, 2012, Volume: 224, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Aging; Animals; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Male; Naltrexone; Nicotine; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Tobacco Use Disorder

2012
Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.
    Behavioural brain research, 2014, May-15, Volume: 265

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-2 Receptor Antagonists; Analgesics, Non-Narcotic; Animals; Conditioning, Operant; Drug Administration Schedule; Drug Interactions; Extinction, Psychological; Male; Naltrexone; Nicotine; Nicotinic Agonists; Rats; Rats, Long-Evans; Receptors, Opioid, kappa; Self Administration; Stress, Psychological; Tobacco Use Disorder; Yohimbine

2014
Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine.
    Behavioural brain research, 2018, 02-15, Volume: 338

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Avoidance Learning; Conditioning, Operant; Male; Naltrexone; Narcotic Antagonists; Nicotine; Rats; Rats, Wistar; Receptors, Opioid, kappa; Taste

2018
Kappa opioid receptors mediate yohimbine-induced increases in impulsivity in the 5-choice serial reaction time task.
    Behavioural brain research, 2019, 02-01, Volume: 359

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Attention; Choice Behavior; Dose-Response Relationship, Drug; Ethanol; Impulsive Behavior; Male; Neurotransmitter Agents; Nicotine; Rats, Long-Evans; Receptors, Opioid, kappa; Yohimbine

2019
Pharmacological activation of kappa opioid receptors in the nucleus accumbens core and ventral tegmental area increases the aversive effects of nicotine.
    Behavioural pharmacology, 2022, 06-01, Volume: 33, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Nicotine; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Opioid, kappa; Tobacco Use Disorder; Ventral Tegmental Area

2022